Page 138 | Middle Market Growth

Biden’s Anti-monopoly FTC Pick Could be a Blessing for Buyers | Middle-Market Public Policy Roundup

March 10, 2021 Kathryn Mulligan

Biden expects to name antitrust scholar to the FTC, which could provide opportunities for investors, a third COVID-19 relief bill heads to final approval, and the Fed continues PPP support.

Healthcare

A Better Approach to Treating Chronic Disease

March 8, 2021 Kathryn Mulligan

The growth in chronic disease has been steep and steady in recent years—but here's where investors can help.

MMGWinter2021_TrendFeature_HeroImage_1280x720px

Deal Execution

The Health Tech Boom

March 5, 2021 Kathryn Mulligan

The last year revealed the challenges within the health care industry and drawn investors’ attention to companies with technology solutions that promise to make it more efficient and effective.

Gensler Open to Using ‘All’ SEC Authorities to Increase PE Transparency | Middle-Market Public Policy Roundup

March 3, 2021 Kathryn Mulligan

Biden's SEC pick says he's committed to increasing PE transparency, the SEC prepares for a meeting on SPACs, and the next stimulus package heads to the Senate.

MMGWinter2021_CoverStory1_HeroImage_1280x720px

Deep Dives

Health Care’s Retail Revolution

March 2, 2021 Kathryn Mulligan

The patient experience is shaping the way care is delivered, and it’s prompting health care providers to rethink their offerings and how they measure business performance.

The Middle Market Case for Outsourcing

March 2, 2021 Kathryn Mulligan

By enlisting third-party expertise, firms can efficiently respond to investor demands and streamline their operations to help support strategic planning.